Helicobacter pylori IgA and IgG antibodies, serum pepsinogen I and the risk of gastric cancer: Changes in the risk with extended follow-up period

International Journal of Cancer

Volumn 119, Issue 3, 2006, Pages 702-705

  Knekt, Paul ^a,b   Teppo, Lyly ^c   Aromaa, Arpo ^a   Rissanen, Harri ^a   Kosunen, Timo U ^d  

^a NATIONAL PUBLIC HEALTH INSTITUTE   (Finland)

^b SOCIAL INSURANCE INSTITUTION   (Finland)

^c FINNISH CANCER REGISTRY   (Finland)

^d UNIVERSITY OF HELSINKI   (Finland)

Author keywords

Gastric cancer; H. Pylori; IgA antibodies; IgG antibodies; Pepsinogen I

Indexed keywords

IMMUNOGLOBULIN A ANTIBODY; IMMUNOGLOBULIN G ANTIBODY; PEPSINOGEN I;

ADENOCARCINOMA; ADULT; AGED; ANTIBODY TITER; ARTICLE; CANCER CLASSIFICATION; CANCER INCIDENCE; CANCER RISK; CARDIA CARCINOMA; CASE CONTROL STUDY; CONTROLLED STUDY; FEMALE; FINLAND; FOLLOW UP; HELICOBACTER PYLORI; HISTOLOGY; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; STOMACH CANCER;

AGED; AGED, 80 AND OVER; ANTIBODIES, BACTERIAL; CASE-CONTROL STUDIES; COHORT STUDIES; CONFIDENCE INTERVALS; FEMALE; FINLAND; FOLLOW-UP STUDIES; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; INCIDENCE; LOGISTIC MODELS; MALE; MIDDLE AGED; ODDS RATIO; PEPSINOGEN A; REGISTRIES; RISK FACTORS; STOMACH NEOPLASMS; TIME FACTORS;

EID: 33745453271     PISSN: 00207136     EISSN: 10970215     Source Type: Journal    
DOI: 10.1002/ijc.21884     Document Type: Article

References (25)

1. Correa P, Haenszel W, Cuello C, Zavala D, Fontham E, Zarama G, Tannenbaum S, Collazos T, Ruiz B. Gastric precancerous process in a high risk population: cohort follow-up. Cancer Res 1990;50:4737-40.
2. International Agency for Research on Cancer. Infection with Helicobacter pylori. IARC Monogr Eval Carcinog Risks Hum 1994;61:177-240.
3. Helicobacter and Cancer Collaborative Group. Gastric cancer and Helicobacter pylori: a combined analysis of 12 case control studies nested within prospective cohorts. Gut 2001;49:347-53.
4. Kosunen TU, Seppalä K, Sarna S, Sipponen P. Diagnostic value of decreasing IgG, IgA, and IgM antibody titres after eradication of Helicobacter pylori. Lancet 1992;339:893-5.
5. Aromaa A, Kosunen TU, Knekt P, Maatela J, Teppo L, Heinonen OP, Härkönen M, Hakama MK. Circulating anti-Helicobacter pylori immunoglobulin A antibodies and low serum pepsinogen I level are associated with increased risk of gastric cancer. Am J Epidemiol 1996;144:142-9.
6. Knekt P, Aromaa A. Maatela J, Aaran R-K, Nikkari T, Hakama M, Hakulinen T, Peto R, Saxén E, Teppo L. Serum vitamin E and risk of cancer among Finnish men during a 10-year follow-up. Am J Epidemiol 1988;127:28-41.
7. Teppo L, Pukkala E, Lehtonen M. Data quality and quality control of a population-based cancer registry. Experience in Finland. Acta Oncol 1994;33:365-9.
8. Kosunen TU, Aromaa A, Knekt P, Salomaa A, Rautelin H, Lohi P. Heinonen OP. Helicobacter antibodies in 1973 and 1994 in the adult population of Vammala. Finland. Epidemiol Infect 1997;119:29-34.
9. Tamm A, Villako K, Härkönen M, Karonen SL. Serum pepsinogen I and the state of gastric mucosa in an Estonian population sample. Scand J Gastroenterol 1984;19:1091-4.
10. Kurki R, Linder E, Miettinen A, Alfthan O, Heikkinen A, Pastemack A. Tissue antibodies in malignant and benign urogenital disease. Int J Cancer 1977;19:332-6.
11. Breslow NE, Day NE. Statistical methods in cancer research, volume 1: the analysis of case-control studies. IARC Sci Publ 1980;32:5-338.
12. Fleiss JL. Statistical methods for rates and proportions. New York: Wiley, 1981.
13. Huang JQ, Sridhar S, Chen Y, Hunt RH. Meta-analysis of the relationship between Helicobacter pylori seropositivity and gastric cancer. Gastroenterology 1998;114:1169-79.
14. Rautelin HI, Oksanen AM, Karttunen RA, Seppälä KM, Virtamo JR, Aromaa AJ, Kosunen TU. Association of CagA-positive infection with Helicobacter pylori antibodies of IgA class. Ann Med 2000;32:652-6.
15. Cover TL, Glupczynski Y, Lage AP, Burette A, Tummuru MK, Perez-Perez GI, Blaser MJ. Serologic detection of infection with cagA+ Helicobacter pylori strains. J Clin Microbiol 1995;33:1496-500.
16. Parsonnet J. Friedman GD, Orentreich N, Vogelman H. Risk for gastric cancer in people with CagA positive or CagA negative Helicobacter pylori infection. Gut 1997;40:297-301.
17. Held M, Engstrand L, Hansson LE, Bergstrom R, Wadstrom T, Nyren O. Is the association between Helicobacter pylori and gastric cancer confined to CagA-positive strains? Helicobacter 2004;9:271-7.
18. Crabtree JE, Taylor JD, Wyatt JI, Heatley RV, Shallcross TM, Tompkins DS, Rathbone BJ. Mucosal IgA recognition of Helicobacter pylori 120 kDa protein, peptic ulceration, and gastric pathology. Lancet 1991;338:332-5.
19. Yamaoka Y, Kita M, Kodama T, Sawai N, Kashima K, Imanishi J. Induction of various cytokines and development of severe mucosal inflammation by cagA gene positive Helicobacter pylori strains. Gut 1997;41:442-51.
20. Kekki M, Samloff IM, Varis K, Ihamäki T. Serum pepsinogen I and serum gastrin in the screening of severe atrophic corpus gastritis. Scand J Gastroenterol Suppl 1991;186:109-16.
21. Burman P, Karlsson FA, Loof L, Axelsson CK, Szesci PB, Borch K. H+,K-ATPase antibodies in autoimmune gastritis: observations on the development of pernicious anemia. Scand J Gastroenterol 1991;26:207-14.
22. Oksanen A, Sipponen P, Karttunen R, Miettinen A, Veijola L, Sarna S, Rautelin H. Atrophic gastritis and Helicobacter pylori infection in outpatients referred for gastroscopy. Gut 2000;46:460-3.
23. Samloff IM, Varis K, Ihamäki T, Siurala M, Rotter JI. Relationships among serum pepsinogen I, serum pepsinogen II, and gastric mucosal histology. A study in relatives of patients with pernicious anemia. Gastroenterology 1982;83:204-9.
24. Kravetz RE, Van Noorden S, Spiro HM. Parietal-cell antibodies in patients with duodenal ulcer and gastric cancer. Lancet 1967;1:235-7.
25. Kokkola A, Kosunen TU, Puolakkainen P, Sipponen P, Härkönen M, Laxen F, Virtamo J, Haapiainen R, Rautelin H. Spontaneous disappearance of Helicobacter pylori antibodies in patients with advanced atrophic corpus gastritis. APMIS 2003;111:619-24.